Developmental compensation in congenital NaV1.7-deficient individuals may explain the disconnect between human genetics and pharmacology
SGLT2 Antagonists A new class of orally administered compounds that targets renal glucose transport and inducers of glucosuria are currently being tested for efficacy in type 2 diabetes treatment
The FDA has expressed concern that pharmacies are using cheaper, substandard ingredients to make GLP-1s
Cushings syndrome is another rare but serious condition that results in high levels of cortisol, causing fat to accumulate around the face, back, and abdomen
By combining weight loss drugs with lifestyle coaching and medical expertise, we help patients reclaim their health and confidence in a way thats safe, effective, and sustainable
2003 [cited 2020 Sep 9];92:182131